Logo image of U6Z.DE

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

FRA:U6Z - Deutsche Boerse Ag - US9168961038 - Common Stock - Currency: EUR

5.622  +1.1 (+24.23%)

Fundamental Rating

3

Taking everything into account, U6Z scores 3 out of 10 in our fundamental rating. U6Z was compared to 59 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for U6Z as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, U6Z is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

U6Z had negative earnings in the past year.
U6Z had a negative operating cash flow in the past year.
In the past 5 years U6Z reported 4 times negative net income.
U6Z had negative operating cash flow in 4 of the past 5 years.
U6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFU6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

U6Z's Return On Assets of -6.64% is on the low side compared to the rest of the industry. U6Z is outperformed by 91.53% of its industry peers.
U6Z has a Return On Equity of -7.43%. This is amonst the worse of the industry: U6Z underperforms 88.14% of its industry peers.
Industry RankSector Rank
ROA -6.64%
ROE -7.43%
ROIC N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
U6Z.DE Yearly ROA, ROE, ROICU6Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

U6Z has a Gross Margin of 36.62%. This is comparable to the rest of the industry: U6Z outperforms 40.68% of its industry peers.
U6Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
U6Z.DE Yearly Profit, Operating, Gross MarginsU6Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

8

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, U6Z has more shares outstanding
The number of shares outstanding for U6Z has been increased compared to 5 years ago.
U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
U6Z.DE Yearly Shares OutstandingU6Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
U6Z.DE Yearly Total Debt VS Total AssetsU6Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

U6Z has an Altman-Z score of 12.12. This indicates that U6Z is financially healthy and has little risk of bankruptcy at the moment.
U6Z has a better Altman-Z score (12.12) than 96.61% of its industry peers.
U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.12
ROIC/WACCN/A
WACC10.36%
U6Z.DE Yearly LT Debt VS Equity VS FCFU6Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 9.44 indicates that U6Z has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.44, U6Z belongs to the best of the industry, outperforming 96.61% of the companies in the same industry.
U6Z has a Quick Ratio of 4.39. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
U6Z's Quick ratio of 4.39 is amongst the best of the industry. U6Z outperforms 93.22% of its industry peers.
Industry RankSector Rank
Current Ratio 9.44
Quick Ratio 4.39
U6Z.DE Yearly Current Assets VS Current LiabilitesU6Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -300.00% in the last year.
U6Z shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.54%.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-532.14%
Revenue 1Y (TTM)12.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42787.93%

3.2 Future

Based on estimates for the next years, U6Z will show a very strong growth in Earnings Per Share. The EPS will grow by 57.12% on average per year.
U6Z is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 57.99% yearly.
EPS Next Y-38.88%
EPS Next 2Y115.67%
EPS Next 3Y116.02%
EPS Next 5Y57.12%
Revenue Next Year129.43%
Revenue Next 2Y69.88%
Revenue Next 3Y73.7%
Revenue Next 5Y57.99%

3.3 Evolution

U6Z.DE Yearly Revenue VS EstimatesU6Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
U6Z.DE Yearly EPS VS EstimatesU6Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

U6Z reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 59.95, U6Z can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, U6Z is valued a bit more expensive than 74.58% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. U6Z is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 59.95
U6Z.DE Price Earnings VS Forward Price EarningsU6Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U6Z.DE Per share dataU6Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as U6Z's earnings are expected to grow with 116.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115.67%
EPS Next 3Y116.02%

More info and screens

0

5. Dividend

5.1 Amount

U6Z does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URANIUM ENERGY CORP

FRA:U6Z (5/23/2025, 7:00:00 PM)

5.622

+1.1 (+24.23%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-18 2025-03-18
Earnings (Next)06-05 2025-06-05
Inst Owners78.72%
Inst Owner ChangeN/A
Ins Owners1.9%
Ins Owner ChangeN/A
Market Cap2.41B
Analysts80
Price Target9.16 (62.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)141.88%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)284.82%
Revenue beat(4)1
Avg Revenue beat(4)20.94%
Min Revenue beat(4)-100%
Max Revenue beat(4)284.82%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.63%
PT rev (3m)-11.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-186.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-32.36%
Revenue NY rev (3m)-32.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 59.95
P/S 40.78
P/FCF N/A
P/OCF N/A
P/B 3.11
P/tB 14.86
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.09
Fwd EY1.67%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.14
BVpS1.81
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.64%
ROE -7.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.62%
FCFM N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 220.65%
Cap/Sales 5.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.44
Quick Ratio 4.39
Altman-Z 12.12
F-Score5
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)135.76%
Cap/Depr(5y)103.6%
Cap/Sales(3y)511.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-532.14%
EPS Next Y-38.88%
EPS Next 2Y115.67%
EPS Next 3Y116.02%
EPS Next 5Y57.12%
Revenue 1Y (TTM)12.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42787.93%
Revenue Next Year129.43%
Revenue Next 2Y69.88%
Revenue Next 3Y73.7%
Revenue Next 5Y57.99%
EBIT growth 1Y-117.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-130.34%
EBIT Next 3Y83.71%
EBIT Next 5Y48.91%
FCF growth 1Y-390.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-347.79%
OCF growth 3YN/A
OCF growth 5YN/A